XOMA Corp (XOMAP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $25.94
• P/E Ratio: 25.86
• EPS: $1.00
• 52-Week High: $28.80
• 52-Week Low: $23.47

Market Sentiment

XOMA Corp currently has a Neutral sentiment score of 0.01.

About XOMA Corp

XOMA Corporation (XOMAP) is a biotechnology firm headquartered in Emeryville, California, specializing in the discovery and development of breakthrough therapeutic candidates. As a prominent royalty aggregator, XOMA strategically partners with global entities to enhance its proprietary technologies and expand its robust pipeline of innovative treatments across various therapeutic areas. With a strong focus on creating value through collaborations and royalty agreements, the company is well-po...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for XOMA Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XOMAP pay dividends?

XOMA Corp (XOMAP) does not currently pay a regular dividend.

What is XOMAP's P/E ratio?

XOMA Corp has a price-to-earnings (P/E) ratio of 25.86.